Physician profile
Stephen E Burpee
NPI 1609831841
$2,430.74
in general payments reported to CMS, 2019-2025
9 companies · $18.90 in 2025
The $18.90 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $47.10 · 2023: $1,251 · 2024: $1,114 · 2025: $18.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,034 · Food and Beverage: $806 · Travel and Lodging: $535 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,034.06 |
| Food and Beverage | $806.11 |
| Travel and Lodging | $534.73 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,077.22 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $105.04 | 2024 | Phasix Mesh |
| Baxter Healthcare | $55.73 | 2023-2024 | Peri-Strips Dry, Tisseel |
| Intra-Sana Laboratories | $54.74 | 2024-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Tela Bio, INC. | $53.08 | 2020-2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $22.89 | 2023 | Durasorb Monofilament Mesh |
| Phathom Pharmaceuticals, INC. | $22.26 | 2024 | Voquezna |
| Novo Nordisk INC | $20.48 | 2020 | |
| Teleflex LLC | $19.30 | 2023 | Titan Sgs Standard Gastric Stapler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Burpee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.